Sign up to save your podcasts
Or
Share Renal Guard CEO Jim Dillon Discusses Spin Out of High Profile Reprieve Cardiovascular
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Renal Guard CEO Jim Dillon Discusses Spin Out of High Profile Reprieve Cardiovascular
Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside investors, including Abiomed, and counts Serial Entrepreneur Howard Levin as chief medical officer.
View all episodes
By Healthegy
4.8
5757 ratings
Jim Dillon, president and CEO of Renal Guard, talks about the company’s decision to create Reprieve Cardiovascular, a start-up focusing on heart failure. Reprieve raised $7 million from outside investors, including Abiomed, and counts Serial Entrepreneur Howard Levin as chief medical officer.
More shows like Medtech Talk
View all
Wait Wait... Don't Tell Me!
38,553 Listeners
Radiolab
43,819 Listeners
Monday Morning Podcast
32,026 Listeners
DeviceTalks Podcast Network
46 Listeners
Global Medical Device Podcast powered by Greenlight Guru
93 Listeners
Pardon My Take
81,701 Listeners
How I Built This with Guy Raz
30,219 Listeners
The Daily
111,530 Listeners
Capital Allocators – Inside the Institutional Investment Industry
814 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
8,685 Listeners
The Ezra Klein Show
15,263 Listeners
This Day in AI Podcast
191 Listeners